<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>78(9)</volume><submitter>Albers GW</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>The optimal imaging approach for identifying patients who may benefit from endovascular thrombectomy (EVT) beyond 6 hours after they were last known well is unclear. Six randomized clinical trials (RCTs) have evaluated the efficacy of EVT vs standard medical care among patients with ischemic stroke.&lt;h4>Objective&lt;/h4>To assess the benefits of EVT among patients with 3 baseline imaging profiles using a pooled analysis of RCTs.&lt;h4>Data sources&lt;/h4>The AURORA (Analysis of Pooled Data from Randomized Studies of Thrombectomy More Than 6 Hours After Last Known Well) Collaboration pooled patient-level data from the included clinical trials.&lt;h4>Study selection&lt;/h4>An online database search identified RCTs of endovascular stroke therapy published between January 1, 2010, and March</pubmed_abstract><journal>JAMA neurology</journal><pagination>1064-1071</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8314176</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Assessment of Optimal Patient Selection for Endovascular Thrombectomy Beyond 6 Hours After Symptom Onset: A Pooled Analysis of the AURORA Database.</pubmed_title><pmcid>PMC8314176</pmcid><pubmed_authors>Demchuk AM</pubmed_authors><pubmed_authors>Shuaib A</pubmed_authors><pubmed_authors>Sila CA</pubmed_authors><pubmed_authors>Marks MP</pubmed_authors><pubmed_authors>Millan M</pubmed_authors><pubmed_authors>Christensen S</pubmed_authors><pubmed_authors>Martins SO</pubmed_authors><pubmed_authors>McTaggart RA</pubmed_authors><pubmed_authors>Cognard C</pubmed_authors><pubmed_authors>Heit JJ</pubmed_authors><pubmed_authors>Lansberg MG</pubmed_authors><pubmed_authors>Haussen DC</pubmed_authors><pubmed_authors>Bhuva P</pubmed_authors><pubmed_authors>Goyal M</pubmed_authors><pubmed_authors>Turk AS</pubmed_authors><pubmed_authors>Liebeskind DS</pubmed_authors><pubmed_authors>AURORA Investigators</pubmed_authors><pubmed_authors>Kim-Tenser M</pubmed_authors><pubmed_authors>Hill M</pubmed_authors><pubmed_authors>Hassan AE</pubmed_authors><pubmed_authors>Bonafe A</pubmed_authors><pubmed_authors>Nogueira RG</pubmed_authors><pubmed_authors>Rebello LC</pubmed_authors><pubmed_authors>Yavagal DR</pubmed_authors><pubmed_authors>Budzik RF</pubmed_authors><pubmed_authors>Tsai JP</pubmed_authors><pubmed_authors>Jadhav AP</pubmed_authors><pubmed_authors>Ribo M</pubmed_authors><pubmed_authors>Hanel RA</pubmed_authors><pubmed_authors>Ortega-Gutierrez S</pubmed_authors><pubmed_authors>Torbey MT</pubmed_authors><pubmed_authors>Albers GW</pubmed_authors><pubmed_authors>Leslie-Mazwi T</pubmed_authors><pubmed_authors>Jovin TG</pubmed_authors><pubmed_authors>Brown S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Assessment of Optimal Patient Selection for Endovascular Thrombectomy Beyond 6 Hours After Symptom Onset: A Pooled Analysis of the AURORA Database.</name><description>&lt;h4>Importance&lt;/h4>The optimal imaging approach for identifying patients who may benefit from endovascular thrombectomy (EVT) beyond 6 hours after they were last known well is unclear. Six randomized clinical trials (RCTs) have evaluated the efficacy of EVT vs standard medical care among patients with ischemic stroke.&lt;h4>Objective&lt;/h4>To assess the benefits of EVT among patients with 3 baseline imaging profiles using a pooled analysis of RCTs.&lt;h4>Data sources&lt;/h4>The AURORA (Analysis of Pooled Data from Randomized Studies of Thrombectomy More Than 6 Hours After Last Known Well) Collaboration pooled patient-level data from the included clinical trials.&lt;h4>Study selection&lt;/h4>An online database search identified RCTs of endovascular stroke therapy published between January 1, 2010, and March</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-05-08T02:35:04.626Z</modification><creation>2024-11-08T16:46:57.169Z</creation></dates><accession>S-EPMC8314176</accession><cross_references><pubmed>34309619</pubmed><doi>10.1001/jamaneurol.2021.2319</doi></cross_references></HashMap>